Wolff Olins has created the new brand identity for global healthcare company GSK (formerly GlaxoSmithKline), aiming to better express its focus on innovation. The agency was brought on board around 18 ...

Look deep into nature and then you will understand everything better.” The quote from Albert Einstein is generally deployed ...

GSK's $1 billion acquisition of IDRx includes IDRX-42, a precision therapy for GIST. Phase 1/1b trial shows 53% ORR in early treatment stages.

the Annual Salary Survey, and supplementary insight from Campaign's Best Places to Work Regular data-led insight reports from Campaign Red, our new global insights and data intelligence tool ...

GSK launched Shingrix in China in 2020. Meanwhile, the company is also investing in additional manufacturing capacity to meet the expected demand, with a new plant due to come online in 2024.

Latin America Cargo City is a single brand of Corporación ... Lacalle Pou “welcomed GSK's announcement of the opening of one of its three new regional vaccine distribution centers in Uruguay”.

The decision is remarkable in that the HIV integrase inhibitor is one of ViiV’s most up-to-date products, only getting FDA approval under the Apretude brand ... GSK also said the new agreements ...

"Relation-GSK to drive fibrotic and osteoarthritis developments" was originally created and published by Pharmaceutical Technology, a GlobalData owned brand. The information on this site has been ...

GSK plans five new product approvals by 2025, highlights strong specialty growth, and acquires IDRx for $1 billion to expand its oncology portfolio.

GSK (GSK) announced that the US Food and Drug ... syringe presentation of Shingrix for the prevention of shingles. The new prefilled syringe removes the need to reconstitute separate vials prior ...